The president of Pfizer, Albert Bourla, said Thursday that he rejects the proposal supported by USA to temporarily suspend patents on vaccines against coronavirus covid-19, and rather suggested accelerating its production in existing plants.
In an interview with AFP, Bourla claimed that his company, which developed a vaccine together with the German BioNTech, is not “at all” in favor of the American call to lift the patents that protect the drug against covid-19.
Some more news:
- France Joins United States In Saying It Is In Favor Of Releasing Patents On COVID-19 Vaccines
- How is the battle to release patents for COVID-19 vaccines that the US has joined?
- Vladimir Putin Supports Releasing Patents for COVID-19 Vaccines
Information in development.
Melissa Galbraith is the World News reporter for Globe Live Media. She covers all the major events happening around the World. From Europe to Americas, from Asia to Antarctica, Melissa covers it all. Never miss another Major World Event by bookmarking her author page right here.